Latest filing published 11 Sept 2025 for Gilead Sciences, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Diane E. Wilfong, listed as finance chief, appears in our data through filings on Gilead Sciences, Inc. shares, published by SEC (Form 4). We count 15 filings; the first trade dates from 10 August 2021 and the latest from 10 September 2025.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 11 September 2025, reports an option exercise in Gilead Sciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations